Log in now to determine if you qualify for a special Research Report offers. Log in

Pharmaceutical Marketing

Pharmaceutical Marketing

This white paper, produced with partner Kantar Media, examines the state of pharma marketing today, how digital information and social-media channels are changing the landscape, the still-evolving regulatory enivronment, the maturing of blockbuster drugs and the opportunities all of that brings.

October 17th, 2011 |

18 pages


By Beth Snyder Bulik

Read

It's been almost 15 years since U.S. direct-to-consumer advertising regulations were loosened. And in those years, the consumer pharmaceutical marketing industry has gone from about $700 million in ad spending to a peak of $5.4 billion in 2006. Spending in 2010, about $4.3 billion, was down, but pharmaceutical advertising remains big business. This free white paper, produced with partner Kantar Media, examines the state of pharma marketing today, how digital information and social-media channels are changing the landscape, the still-evolving regulatory enivronment, the maturing of blockbuster drugs and the opportunities all of that brings.


Interested in licensing this research paper for multiple use? Ask us!

Would you like to be invoiced for this research paper? Ask us!